ImmunoBiota Therapeutics

ImmunoBiota Therapeutics is a company focused on pioneering oral immunotherapies for long-term disease modification and enhanced quality of life for patients, with a lead indication in Type 1 Diabetes. Their therapeutic candidate delivers potent anti-inflammatory metabolites directly in the gut to reverse Type 1 Diabetes without immunosuppression. The company is clinically validating its approach in adults and children with Type 1 Diabetes and hypertension. Their therapy aims to restore immune and microbiome balance, potentially leading to long-term remission and better metabolic control.

• Healthtech

Visit website ↗